• レポートコード:QYR2104Z3448 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、93ページ • 納品方法:Eメール(納期:3日) • 産業分類:医薬品、ヘルスケア |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、生細胞&死細胞生存率アッセイキットのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(哺乳類細胞、酵母菌、菌類、細菌)、用途別市場規模(臨床、微生物、研究所、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・生細胞&死細胞生存率アッセイキットの市場動向 ・企業の競争状況、市場シェア ・生細胞&死細胞生存率アッセイキットの種類別市場規模(哺乳類細胞、酵母菌、菌類、細菌) ・生細胞&死細胞生存率アッセイキットの用途別市場規模(臨床、微生物、研究所、その他) ・生細胞&死細胞生存率アッセイキットの北米市場規模2016-2027(アメリカ、カナダ) ・生細胞&死細胞生存率アッセイキットのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・生細胞&死細胞生存率アッセイキットのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・生細胞&死細胞生存率アッセイキットの中南米市場規模2016-2027(メキシコ、ブラジル) ・生細胞&死細胞生存率アッセイキットの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Thermo Fisher Scientific、Merck、GeneCopoeia、Enzo Biochem、Chondrex、Molecular Devices、Sangon Biotech、ABP Biosciences) ・結論 |
Live/Dead Cell Viability Assay Kit to evaluate cell viability and cell density.The Live-Dead Cell Viability Assay Kit is a quick and simple three-color
assay to measure cell viability.
Market Analysis and Insights: Global Live & Dead Cell Viability Assay Kit Market
The global Live & Dead Cell Viability Assay Kit market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Live & Dead Cell Viability Assay Kit market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Live & Dead Cell Viability Assay Kit market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Live & Dead Cell Viability Assay Kit market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Live & Dead Cell Viability Assay Kit market.
Global Live & Dead Cell Viability Assay Kit Scope and Market Size
Live & Dead Cell Viability Assay Kit market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Live & Dead Cell Viability Assay Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Mammalian Cells
Yeast And Fungi
Bacteria
Segment by Application
Clinical
Microbiology
Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Merck
GeneCopoeia
Enzo Biochem
Chondrex
Molecular Devices
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Live & Dead Cell Viability Assay Kit Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mammalian Cells
1.2.3 Yeast And Fungi
1.2.4 Bacteria
1.3 Market by Application
1.3.1 Global Live & Dead Cell Viability Assay Kit Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical
1.3.3 Microbiology
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Live & Dead Cell Viability Assay Kit Market Perspective (2016-2027)
2.2 Live & Dead Cell Viability Assay Kit Growth Trends by Regions
2.2.1 Live & Dead Cell Viability Assay Kit Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Live & Dead Cell Viability Assay Kit Historic Market Share by Regions (2016-2021)
2.2.3 Live & Dead Cell Viability Assay Kit Forecasted Market Size by Regions (2022-2027)
2.3 Live & Dead Cell Viability Assay Kit Industry Dynamic
2.3.1 Live & Dead Cell Viability Assay Kit Market Trends
2.3.2 Live & Dead Cell Viability Assay Kit Market Drivers
2.3.3 Live & Dead Cell Viability Assay Kit Market Challenges
2.3.4 Live & Dead Cell Viability Assay Kit Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Live & Dead Cell Viability Assay Kit Players by Revenue
3.1.1 Global Top Live & Dead Cell Viability Assay Kit Players by Revenue (2016-2021)
3.1.2 Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Players (2016-2021)
3.2 Global Live & Dead Cell Viability Assay Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Live & Dead Cell Viability Assay Kit Revenue
3.4 Global Live & Dead Cell Viability Assay Kit Market Concentration Ratio
3.4.1 Global Live & Dead Cell Viability Assay Kit Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Live & Dead Cell Viability Assay Kit Revenue in 2020
3.5 Live & Dead Cell Viability Assay Kit Key Players Head office and Area Served
3.6 Key Players Live & Dead Cell Viability Assay Kit Product Solution and Service
3.7 Date of Enter into Live & Dead Cell Viability Assay Kit Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Live & Dead Cell Viability Assay Kit Breakdown Data by Type
4.1 Global Live & Dead Cell Viability Assay Kit Historic Market Size by Type (2016-2021)
4.2 Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Type (2022-2027)
5 Live & Dead Cell Viability Assay Kit Breakdown Data by Application
5.1 Global Live & Dead Cell Viability Assay Kit Historic Market Size by Application (2016-2021)
5.2 Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Live & Dead Cell Viability Assay Kit Market Size (2016-2027)
6.2 North America Live & Dead Cell Viability Assay Kit Market Size by Type
6.2.1 North America Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021)
6.2.2 North America Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027)
6.2.3 North America Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2027)
6.3 North America Live & Dead Cell Viability Assay Kit Market Size by Application
6.3.1 North America Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021)
6.3.2 North America Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027)
6.3.3 North America Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2027)
6.4 North America Live & Dead Cell Viability Assay Kit Market Size by Country
6.4.1 North America Live & Dead Cell Viability Assay Kit Market Size by Country (2016-2021)
6.4.2 North America Live & Dead Cell Viability Assay Kit Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Live & Dead Cell Viability Assay Kit Market Size (2016-2027)
7.2 Europe Live & Dead Cell Viability Assay Kit Market Size by Type
7.2.1 Europe Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021)
7.2.2 Europe Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027)
7.2.3 Europe Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2027)
7.3 Europe Live & Dead Cell Viability Assay Kit Market Size by Application
7.3.1 Europe Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021)
7.3.2 Europe Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027)
7.3.3 Europe Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2027)
7.4 Europe Live & Dead Cell Viability Assay Kit Market Size by Country
7.4.1 Europe Live & Dead Cell Viability Assay Kit Market Size by Country (2016-2021)
7.4.2 Europe Live & Dead Cell Viability Assay Kit Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size (2016-2027)
8.2 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Type
8.2.1 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2027)
8.3 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Application
8.3.1 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2027)
8.4 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Region
8.4.1 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Live & Dead Cell Viability Assay Kit Market Size (2016-2027)
9.2 Latin America Live & Dead Cell Viability Assay Kit Market Size by Type
9.2.1 Latin America Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021)
9.2.2 Latin America Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027)
9.2.3 Latin America Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2027)
9.3 Latin America Live & Dead Cell Viability Assay Kit Market Size by Application
9.3.1 Latin America Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021)
9.3.2 Latin America Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027)
9.3.3 Latin America Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2027)
9.4 Latin America Live & Dead Cell Viability Assay Kit Market Size by Country
9.4.1 Latin America Live & Dead Cell Viability Assay Kit Market Size by Country (2016-2021)
9.4.2 Latin America Live & Dead Cell Viability Assay Kit Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size (2016-2027)
10.2 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Type
10.2.1 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2027)
10.3 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Application
10.3.1 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2027)
10.4 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Country
10.4.1 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Live & Dead Cell Viability Assay Kit Introduction
11.1.4 Thermo Fisher Scientific Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Live & Dead Cell Viability Assay Kit Introduction
11.2.4 Merck Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021)
11.2.5 Merck Recent Development
11.3 GeneCopoeia
11.3.1 GeneCopoeia Company Details
11.3.2 GeneCopoeia Business Overview
11.3.3 GeneCopoeia Live & Dead Cell Viability Assay Kit Introduction
11.3.4 GeneCopoeia Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021)
11.3.5 GeneCopoeia Recent Development
11.4 Enzo Biochem
11.4.1 Enzo Biochem Company Details
11.4.2 Enzo Biochem Business Overview
11.4.3 Enzo Biochem Live & Dead Cell Viability Assay Kit Introduction
11.4.4 Enzo Biochem Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021)
11.4.5 Enzo Biochem Recent Development
11.5 Chondrex
11.5.1 Chondrex Company Details
11.5.2 Chondrex Business Overview
11.5.3 Chondrex Live & Dead Cell Viability Assay Kit Introduction
11.5.4 Chondrex Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021)
11.5.5 Chondrex Recent Development
11.6 Molecular Devices
11.6.1 Molecular Devices Company Details
11.6.2 Molecular Devices Business Overview
11.6.3 Molecular Devices Live & Dead Cell Viability Assay Kit Introduction
11.6.4 Molecular Devices Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021)
11.6.5 Molecular Devices Recent Development
11.7 Sangon Biotech
11.7.1 Sangon Biotech Company Details
11.7.2 Sangon Biotech Business Overview
11.7.3 Sangon Biotech Live & Dead Cell Viability Assay Kit Introduction
11.7.4 Sangon Biotech Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021)
11.7.5 Sangon Biotech Recent Development
11.8 ABP Biosciences
11.8.1 ABP Biosciences Company Details
11.8.2 ABP Biosciences Business Overview
11.8.3 ABP Biosciences Live & Dead Cell Viability Assay Kit Introduction
11.8.4 ABP Biosciences Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021)
11.8.5 ABP Biosciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Live & Dead Cell Viability Assay Kit Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mammalian Cells
Table 3. Key Players of Yeast And Fungi
Table 4. Key Players of Bacteria
Table 5. Global Live & Dead Cell Viability Assay Kit Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Live & Dead Cell Viability Assay Kit Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Live & Dead Cell Viability Assay Kit Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Live & Dead Cell Viability Assay Kit Market Share by Regions (2016-2021)
Table 9. Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Live & Dead Cell Viability Assay Kit Market Share by Regions (2022-2027)
Table 11. Live & Dead Cell Viability Assay Kit Market Trends
Table 12. Live & Dead Cell Viability Assay Kit Market Drivers
Table 13. Live & Dead Cell Viability Assay Kit Market Challenges
Table 14. Live & Dead Cell Viability Assay Kit Market Restraints
Table 15. Global Live & Dead Cell Viability Assay Kit Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Live & Dead Cell Viability Assay Kit Market Share by Players (2016-2021)
Table 17. Global Top Live & Dead Cell Viability Assay Kit Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live & Dead Cell Viability Assay Kit as of 2020)
Table 18. Ranking of Global Top Live & Dead Cell Viability Assay Kit Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Live & Dead Cell Viability Assay Kit Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Live & Dead Cell Viability Assay Kit Product Solution and Service
Table 22. Date of Enter into Live & Dead Cell Viability Assay Kit Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Type (2016-2021)
Table 26. Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Live & Dead Cell Viability Assay Kit Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Application (2016-2021)
Table 30. Global Live & Dead Cell Viability Assay Kit Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Live & Dead Cell Viability Assay Kit Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Live & Dead Cell Viability Assay Kit Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Live & Dead Cell Viability Assay Kit Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Live & Dead Cell Viability Assay Kit Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Live & Dead Cell Viability Assay Kit Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Live & Dead Cell Viability Assay Kit Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Live & Dead Cell Viability Assay Kit Product
Table 65. Thermo Fisher Scientific Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Live & Dead Cell Viability Assay Kit Product
Table 70. Merck Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. GeneCopoeia Company Details
Table 73. GeneCopoeia Business Overview
Table 74. GeneCopoeia Live & Dead Cell Viability Assay Kit Product
Table 75. GeneCopoeia Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021) & (US$ Million)
Table 76. GeneCopoeia Recent Development
Table 77. Enzo Biochem Company Details
Table 78. Enzo Biochem Business Overview
Table 79. Enzo Biochem Live & Dead Cell Viability Assay Kit Product
Table 80. Enzo Biochem Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021) & (US$ Million)
Table 81. Enzo Biochem Recent Development
Table 82. Chondrex Company Details
Table 83. Chondrex Business Overview
Table 84. Chondrex Live & Dead Cell Viability Assay Kit Product
Table 85. Chondrex Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021) & (US$ Million)
Table 86. Chondrex Recent Development
Table 87. Molecular Devices Company Details
Table 88. Molecular Devices Business Overview
Table 89. Molecular Devices Live & Dead Cell Viability Assay Kit Product
Table 90. Molecular Devices Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021) & (US$ Million)
Table 91. Molecular Devices Recent Development
Table 92. Sangon Biotech Company Details
Table 93. Sangon Biotech Business Overview
Table 94. Sangon Biotech Live & Dead Cell Viability Assay Kit Product
Table 95. Sangon Biotech Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021) & (US$ Million)
Table 96. Sangon Biotech Recent Development
Table 97. ABP Biosciences Company Details
Table 98. ABP Biosciences Business Overview
Table 99. ABP Biosciences Revenue in Live & Dead Cell Viability Assay Kit Business (2016-2021) & (US$ Million)
Table 100. ABP Biosciences Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Live & Dead Cell Viability Assay Kit Market Share by Type: 2020 VS 2027
Figure 2. Mammalian Cells Features
Figure 3. Yeast And Fungi Features
Figure 4. Bacteria Features
Figure 5. Global Live & Dead Cell Viability Assay Kit Market Share by Application: 2020 VS 2027
Figure 6. Clinical Case Studies
Figure 7. Microbiology Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Live & Dead Cell Viability Assay Kit Report Years Considered
Figure 11. Global Live & Dead Cell Viability Assay Kit Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Live & Dead Cell Viability Assay Kit Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Live & Dead Cell Viability Assay Kit Market Share by Regions: 2020 VS 2027
Figure 14. Global Live & Dead Cell Viability Assay Kit Market Share by Regions (2022-2027)
Figure 15. Global Live & Dead Cell Viability Assay Kit Market Share by Players in 2020
Figure 16. Global Top Live & Dead Cell Viability Assay Kit Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live & Dead Cell Viability Assay Kit as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Live & Dead Cell Viability Assay Kit Revenue in 2020
Figure 18. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Type (2016-2021)
Figure 19. Global Live & Dead Cell Viability Assay Kit Revenue Market Share by Type (2022-2027)
Figure 20. North America Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Live & Dead Cell Viability Assay Kit Market Share by Type (2016-2027)
Figure 22. North America Live & Dead Cell Viability Assay Kit Market Share by Application (2016-2027)
Figure 23. North America Live & Dead Cell Viability Assay Kit Market Share by Country (2016-2027)
Figure 24. United States Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Live & Dead Cell Viability Assay Kit Market Share by Type (2016-2027)
Figure 28. Europe Live & Dead Cell Viability Assay Kit Market Share by Application (2016-2027)
Figure 29. Europe Live & Dead Cell Viability Assay Kit Market Share by Country (2016-2027)
Figure 30. Germany Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Live & Dead Cell Viability Assay Kit Market Share by Region (2016-2027)
Figure 40. China Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Live & Dead Cell Viability Assay Kit Market Share by Type (2016-2027)
Figure 48. Latin America Live & Dead Cell Viability Assay Kit Market Share by Application (2016-2027)
Figure 49. Latin America Live & Dead Cell Viability Assay Kit Market Share by Country (2016-2027)
Figure 50. Mexico Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Live & Dead Cell Viability Assay Kit Market Share by Country (2016-2027)
Figure 56. Turkey Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Live & Dead Cell Viability Assay Kit Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2016-2021)
Figure 61. GeneCopoeia Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2016-2021)
Figure 62. Enzo Biochem Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2016-2021)
Figure 63. Chondrex Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2016-2021)
Figure 64. Molecular Devices Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2016-2021)
Figure 65. Sangon Biotech Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2016-2021)
Figure 66. ABP Biosciences Revenue Growth Rate in Live & Dead Cell Viability Assay Kit Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed